Also, cxcl10 relative gene expression was higher in fibroblasts treated with BAL obtained from SSc-ILD patients [1.6 × 10−5 (1.1 × 10−5 to 2.4 × 10−5)] compared to controls [1.6 × 10−6 (5.6 × 10−7 to 3.3 × 10−6), P = 0.002, 95% CI: 6.8 × 10−6 to 2.3 × 10−5]. The gene discussed is CXCL10; the disease is systemic sclerosis.